There is a non-invasive, safe and painless way of obtaining important information about the health of an unborn baby based on a sample of maternal blood. TRISOMY test, TRISOMY test XY and TRISOMY test + are non-invasive prenatal screening tests designed to exclude selected foetal chromosomal abnormalities as early as in the first three months of pregnancy.
Non-invasive, safe and painless TRISOMY test
TRISOMY test is a non-invasive high-precision screening test based on maternal blood which is used to determine the presence of frequent foetal chromosomal abnormalities as early as in the 11th week of pregnancy.
TRISOMY test detects the risk of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). IT can also determine the sex of your unborn baby.
Posing no risk to either mothers or their unborn babies, TRISOMY test can identify potential false positive results in prenatal biochemical screening, minimising the number of amniocenteses.
TRISOMY test XY
As an extented version of our TRISOMY test, TRISOMY test XY is capable of identifying not only the most frequently occurring trisomy types (trisomy 21, 18, and 13) but also the most frequently occurring sex chromosome disorders. The test can also determine the sex of an unborn baby based on chromosome analysis.
TRISOMY test +
TRISOMY test + detects the risk of trisomy 21, 18, and 13, sex chromosome number aberrations, and selected chromosome microdeletions, which occur when a chromosome is missing a part. TRISOMY test + can also determine the sex of an unborn baby based on chromosome analysis.